Lev Facher

Washington Correspondent

Lev Facher is a Washington Correspondent for STAT, reporting on the politics of health and life sciences. He has written extensively about the federal government's response to the opioid crisis, the pharmaceutical industry's influence on Capitol Hill, and federally funded biomedical research. Lev earned an economics degree from the University of Michigan, where he worked as managing editor of The Michigan Daily. You can reach him via email at lev.facher@statnews.com and by phone/WhatsApp/Signal at (510)-374-8880.

Donald Trump - improving free inquiry, transparency, and accountability

Politics

The ‘Big Pharma’ candidate? As he runs for president, Cory Booker looks to shake his reputation for drug industry coziness

By Lev Facher

Politics

Lev Facher

Washington Correspondent

Will Trump’s new free speech order affect research funding?

A believer in biotech and big data: How Ned Sharpless vaulted to the top of the FDA

Ned Sharpless, director of the National Cancer Institute, to be named acting FDA commissioner

Trump budget pitches capping seniors’ out-of-pocket drug costs, cutting NIH funding

GOP lawmakers lambaste Democratic push to strip patents from drug companies

With Gottlieb’s resignation, the Trump administration loses its backroom whisperer on Capitol Hill

FDA Commissioner Scott Gottlieb to resign

States, eager to lower drug prices, regroup after courts strike down Maryland ‘price-gouging’ law

NIH apologizes for its failure to address sexual harassment in science

Webinar: Is the new Congress ready to lower drug costs?

In muted hearing, pharma execs dodge attempts to pin blame for high prices

‘A dark and elaborate art’: How pharma executives are training to avoid disaster at Tuesday’s congressional grilling

Supreme Court deals a fatal blow to Maryland drug ‘price gouging’ law

The ‘Big Pharma’ candidate? As he runs for president, Cory Booker looks to shake his reputation for drug industry coziness

An ambassador to the Vatican. A GOP megadonor. And now, a rare Republican joining Democrats to take on pharma

Another potential 2020 hopeful, Sen. Sherrod Brown, backs a Medicare drug negotiation bill

NIH asks inspector general to investigate 12 allegations of foreign influence in U.S. research

As Trump calls on Congress to lower drug prices, some Democrats cheer. Others scoff

Lev Facher

Washington Correspondent

Sign up for our Daily Recap newsletter